JOUNCE THERAPEUTICS INC
CUSIP 481116101
Jounce Therapeutics Inc has 73 institutional holders in Filings Flow’s 13F database, together reporting 23.47M shares worth $20M as of Q4 2022. The largest reported holders are Opaleye Management Inc., Jefferies Group LLC, and Manufacturers Life Insurance Company, The.
Institutional Holders
73
Q4 2022
Reported Value
$20M
Ticker
unmapped
private placement or foreign
Quarters Tracked
7
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Opaleye Management Inc.$759M AUM | 0.22% | $917,823 | 669.9K | Q2 2023OLDER |
| Jefferies Group LLC$12.0B AUM | 0.00% | $309,149 | 132.1K | Q3 2023 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE$116.3B AUM | 0.00% | $104,423 | 15.4K | Q2 2023OLDER |
| CIBC Private Wealth Group LLC$59.2B AUM | 0.00% | $55,500 | 30.0K | Q3 2023 |
| STRS OHIO$25.2B AUM | 0.00% | $14,000 | 8.2K | Q2 2023OLDER |
| Belvedere Trading LLC$84.4B AUM | 0.00% | $6,327 | 5.7K | Q4 2022OLDER |
| CITADEL ADVISORS LLC$618.5B AUM | 0.00% | $23,680 | 12.8K | Q1 2023OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.